BACKGROUND: Patient safety is a national priority. Patient Safety Indicators (PSIs) monitor potential adverse events during hospital stays. Surgical specialty PSI benchmarks do not exist, and are needed to account for differences in the range of procedures performed, reasons for the procedure, and differences in patient characteristics. A comprehensive profile of adverse events in vascular surgery was created. STUDY DESIGN: The Nationwide Inpatient Sample was queried for 8 vascular procedures using ICD-9-CM codes from 2005 to 2009. Factors associated with PSI development were evaluated in univariate and multivariate analyses.
Patient safety has become a national priority since the Institute of Medicine's 1999 landmark report, To Err is Human. 1 Preventable adverse events are associated with increased mortality rates, longer length of stay, and more frequent readmissions. [2] [3] [4] [5] [6] The Agency for Healthcare Research and Quality (AHRQ) has established a set of quality indicators to monitor preventable adverse events during hospitalization, known as Patient Safety Indicators (PSIs). 7 Data generated from these quality indicators can help evaluate hospital performance, safety improvement efforts, and can be used for hypothesis generation. To ensure these data produce meaningful rates, a system of risk adjustment must be in place that fully accounts for differences in patient demographics and comorbidity.
Vascular surgery practices vary in the range of procedures they offer, which in turn vary in complexity and periprocedural risk of death and complications. Recent studies have shown that adverse events are concentrated in a small number of procedure types and rates vary across patient characteristics. 5, 8 Any one vascular procedure can be performed for different reasons that reflect different levels of disease severity, which can influence unadjusted rates of events. For instance, the same lowerextremity bypass (LEB) can be performed for gangrene of the foot to prevent amputation, or alternatively for intermittent claudication, an ambulation-limiting condition. Comparison of outcomes among different vascular surgery practices must therefore account for potential differences in the range of procedures being performed, the reason (indication) for the procedures, as well as differences in patient characteristics.
Given the increasing use of PSIs to evaluate hospital performance, [9] [10] [11] it is important to have a comprehensive profile of adverse events within different surgical specialties. PSI risk-adjusted rates in vascular surgery are needed to profile quality health care delivery in this domain, given the different levels of complexity seen within this group. The aim of our research was to develop patient safety benchmarks for vascular surgery using PSIs to estimate a typical risk-adjusted profile. In this article, we report our efforts to characterize patterns of PSIs after vascular surgery. We chose 8 major surgical procedures commonly performed by vascular surgeons. These procedure-specific profiles can be used as benchmarks and highlight areas where quality-improvement efforts can be focused.
METHODS

Data source
Our source for data was the Nationwide Inpatient Sample (NIS) database. 12 AHRQ's Healthcare Cost and Utilization Project distributes this database. The NIS represents approximately 20% of all hospitalizations across the United States. The NIS includes up to 25 diagnosis codes, 15 procedure codes, and both patient and hospital demographics. These data are weighted to provide a nationally representative sample of all-payer inpatient hospitalizations in the United States.
PSIs
PSIs were developed to screen large administrative databases for preventable adverse events after operations, medical procedures, and childbirth. 7 These indicators are based on ICD-9-CM codes and Medicare severity DRGs and each PSI has specific inclusion and exclusion criteria. 11, 13 The PSI software (version 4.1b) was used to identify preventable adverse events in our dataset and provide risk adjustments; each PSI includes a unique set of adjustors. 14 Patients were assigned to only one vascular procedure group based on their principal procedure. Other endovascular procedures, such as angioplasty and insertion of stents, were not included in the analyses, as the majority of these procedures were not coded as the principal procedure and they were performed mainly in combination with other vascular procedures included in the study. In addition, nonvascular surgeons, such as cardiologists and interventional radiologists, perform many of these endovascular procedures. Patients younger than 18 years and nonelective admissions were excluded, including patients with ruptured aneurysms. Patients undergoing amputation for cancer or trauma were also excluded.
We defined indication for surgery for patients who underwent any of the 3 procedures designed to correct lowerextremity arterial occlusive disease (ie, LEE, AFB, and LEB) with ICD-9-CM diagnosis codes: claudication, 440.21; rest pain, 440.22; ulceration, 440.23; or gangrene, 440.24.
Categories of hospital volume were based on the average annual number of vascular surgery procedures performed during the 5-year study period; a vascular procedure was defined as 1 of the 8 surgical procedures included in our study. Hospital volume was divided into tertiles and the average of the lower and upper tertiles were taken across the 5 study years, a methodology reported previously. 16 Lowvolume hospitals were defined as those performing Ͻ9 
Statistical analysis
Because the NIS is a 20% sample of hospitalizations in the United States, sample weights were applied to the raw data to produce nationally representative estimates. Patient and hospital characteristics were compared between patients with at least one PSI vs those without a PSI using Rao-Scott chi-square for categorical variables and Student's t-test for continuous variables. The Wilcoxon rank sum test was used for analyses of length of stay and total hospital charges because these data are not normally distributed. All rates reported are per 1,000 patients (hospital admissions), unless otherwise specified. The association between hospital volume and hospital risk-adjusted PSI rates was analyzed using a negative binomial regression model. Multivariate logistic regression models were performed to evaluate the association of PSI development with patient and hospital characteristics, taking into account hospital random effects. The AHRQ PSI software flags patient discharges with ICD-9-CM codes corresponding to each PSI, applies external cause of injury codes (e-codes), and calculates crude, estimated, and risk-adjusted incidence rates. 17 For this study, we report PSI risk-adjusted rate generated by the PSI software, which are adjusted for age, sex, age-sex interactions, DRG, and comorbidities as assessed using the Elixhauser Comorbidity Index. 18 PSI software was developed to ensure each PSI denominator includes only patients at risk for each individual event and, therefore, PSI rates give the number of cases divided by the number of patients at risk. The number of patients at risk for each PSI varies according to its specific inclusion and exclusion criteria. 19 We first compared patient and hospital characteristics associated with the development of any PSI using univariate analysis, this dichotomous variable included any PSI development. Next, we generated a multivariate regression model, fitted by hospital random effects using GLIMMIX, to determine the association between PSI development and different patient and hospital characteristics from the univariate analyses. As a third step in the analyses, we used the PSI software to generate standardized PSI risk-adjusted rates. Next, we ran the PSI software on all other surgical patients in the 2009 NIS database to obtain standardized PSI risk-adjusted rate for these patients. These data were used to compare PSI risk-adjusted rate between vascular surgery patients and all other surgical patients. Finally, we examined the association between procedure indication, reasons for having a procedure, and odds of developing a PSI using an additive multivariate regression model, taking into account hospital random effects. The first model in this final analysis included only procedure indication as an independent variable (model 1). We next added patient demographics to the model (model 2) and then added patient comorbidities (model 3). The final model contained model 3 plus hospital characteristics, including hospital volume, teaching status, metropolitan area, and region (model 4).
All analyses accounted for the survey-design nature of the NIS data and were performed using SAS software 9.2 (SAS Institute Inc.). (Table 1) . CEA was the most frequently performed operation, accounting for 40% of the sample. Procedures to treat lowerextremity arterial occlusive disease (ie, LEE, AFB, and LEB) together accounted for 33%, major amputations (eg, BKA and AKA) comprised 18%, and treatments for aortic Table 2 . We examined the data in both univariate and multivariate analyses, with development of any PSI(s) (yes or no) as the dependent variable for the model. The 73,135 vascular Hospital characteristics are also reported in Table 2 . In the group of patients with at least one PSI, more patients went to low-volume hospitals compared with patients without a PSI (p Ͻ 0.0001). Correspondingly, hospital volume predicted the likelihood of developing at least 1 PSI after a vascular operation (p Ͻ 0.0001), with mid and low-volume hospitals having 17% and 69% greater odds of PSI development, respectively. Figure 1 depicts the relationships between hospital volume and risk-adjusted rate of 4 individual PSIs in vascular surgery: PSI #3 (Pressure Ulcer), PSI #4 (Death among Surgical Inpatients with Serious Treatable Complications), PSI #12 (Postoperative Pulmonary Embolism/Deep Vein Thrombosis), and PSI #13 (Postoperative Sepsis). These 4 PSIs were displayed, as they have the highest risk-adjusted rate in vascular surgery. These data illustrate the negative correlation between hospital volume and risk-adjusted PSI rates, a linear increase in volume was associated with lower hospital PSI riskadjusted rates. For each of these PSIs, the negative correlation between hospital volume and event rate was statistically significant. Coefficients from the negative binomial distribution include PSI #3 estimate: Ϫ0.0089, p Ͻ 0.0001; PSI #4 estimate: Ϫ0.0245, p ϭ 0.0033; PSI #12 estimate: Ϫ0.0028, p Ͻ 0.0001; PSI #13 estimate: Ϫ0.0061, p ϭ 0.0048). These coefficients relate to the slope of the relationship between hospital vascular volume and PSI rate, with the steepest gradient for PSI 4, Death among Surgical Inpatients with Serious Treatable Complications.
PSI risk-adjusted rates for patients undergoing the 8 selected vascular procedures were compared with all other surgical inpatients from the 2009 NIS in Table 3 . Vascular patients had significantly higher risk-adjusted PSI rates for pressure ulcers (#3), central-line bloodstream infections (#7), and postoperative pulmonary embolism/deep vein thrombosis (#12), and lower PSI rates for death among surgical inpatients with serious treatable complications (#4), postoperative hemorrhage/hematoma (#9), postoperative respiratory failure (#11), and accidental puncture/ laceration (#15). However, postoperative respiratory failure had significantly higher risk-adjusted rate for open AAA, AFB, and AKA (p Ͻ 0.001). We next looked at PSI risk-adjusted rates in vascular patients by surgical procedure. AKAs had significantly higher risk-adjusted PSI rates compared with all other vascular procedures. CEA and EVAR had significantly lower PSI rates compared with other vascular procedures.
We compared the frequency of any PSI by procedure indication for procedures designed to correct lowerextremity arterial occlusive disease (eg, LEE, AFB and LEB) ( Table 4 ). In the group of patients with a PSI, more patients had gangrene compared with the group of patients without a PSI (17% vs 11%; p Ͻ 0.0001) and a significantly lower proportion were claudicants compared with patients without any PSI (15% vs 28%; p Ͻ 0.0001). We examined PSIs in the relevant procedures by procedure indication. PSI risk-adjusted rate increased linearly by severity of patient indication: claudication, rest pain, ulcers, and gangrene (Fig. 2) . Overall risk-adjusted rates were lowest in claudicants, followed by rest pain and then ulcer patients, with gangrene patients having the highest riskadjusted rates for PSIs.
We then examined the procedure indication relationship in a multivariate regression model for LEB, as an example. The baseline model contained only procedure indication as the independent variable and PSI development as the dependent variable (yes or no). An independent, negative association between procedure indicators claudicant and rest pain and development of a PSI was revealed (OR ϭ 0.40; 95% CI, 0.35-0.46; OR ϭ 0.78; 95% CI, 0.69-0.90, respectively). A strong, independent, positive association was revealed for ulcer and gangrene patients and development of a PSI (OR ϭ 1.20; 95% CI, 1.07-1.34; OR ϭ 1.85; 95% CI, 1.66-2.06, respectively) (Table 5 , model 1). Adjusting the models to account for both patient and hospital characteristics (Table 5, models 2 to 4) revealed small effects in the odds ratios for the indicators. The final model, model 4, contained procedure indicator, age, sex, race, payer, patient comorbidities, hospital volume, hospital teaching status, hospital urban location, and hospital region. Patient sex, race, primary payer, and hospital characteristics had minimal effect on the contribution of the procedure indicator and patient comorbidities had large effects on the overall point estimate of the procedure indicator. In the final adjusted models, procedure indicators remained sig- 9.0 (6.9-11.1) 
DISCUSSION
This report characterizes the current status of preventable adverse events in patients undergoing vascular surgery in the United States. For the majority of the PSIs in this report, risk-adjusted rates were significantly higher in vascular patients compared with 2009 national estimates for all other surgical at-risk patients. Our analyses indicate that adverse events, captured by PSIs, occur in 5% of patients undergoing a vascular procedure, and that there are large variations in rates of adverse events and complication rates by procedure type among different patient characteristics, and by procedure indication, especially for open operations. In addition, these data highlight areas in vascular surgery, such as AKAs in gangrene patients, where qualityimprovement efforts can be focused. Our data confirm previous studies that there are major disparities in the development of any PSI by race, sex, and payer, and these differences remain in vascular operations. [20] [21] [22] In our study, PSIs were more frequent in female, nonwhite patients with public payers. Similar to other studies, 21 we found blacks had considerably higher odds of a PSI developing compared with whites. Clement and colleagues reported that payer is associated with the development of a PSI. 22 Our data further investigated this relationship and showed consistent results, with an adverse event developing in a higher percentage of Medicaid recipients during their hospitalization for vascular surgery compared with patients with other payers. These associations remained after accounting for other known confounders. Some of these characteristics can track with less access to primary care and deferral of seeking medical services. Additional investigation into these discrepancies is needed to better understand the reasons for these elevated rates in minority women with public payers before these differences can be eliminated.
Significant differences in risk-adjusted rates of PSIs by type of procedure were noted. The most commonly performed vascular procedure, CEA, had significantly lower PSI risk-adjusted rates compared with that of all other surgical inpatients, and the rates for EVAR were only slightly higher than CEA, but still significantly lower than all other surgical patients. These procedures are performed with small incisions and are usually followed by short postoperative recovery. In contrast, patients with AKAs and BKAs and open AAA had overall significantly higher PSI risk-adjusted rates compared with other surgical patients, probably reflecting the high burden of comorbidities among vascular amputation patients that is not captured in current PSI risk-adjustment and an obligatory long postoperative stay. These patients' arterial disease is so advanced that it is not remediable, or they have been judged to be too ill or frail to undergo attempts at limb salvage. They might have been hospitalized for days before amputation, are frequently malnourished, and might not have walked for months because of foot wounds. These stark differences, also described by others, 5 show that any quality benchmarks using PSI rates for vascular surgery must account for the range and variety of procedures being performed.
In addition, our data suggest that vascular patients have higher risk-adjusted rates of pulmonary embolism/deep vein thrombosis compared with all other surgical patients, a finding also noted elsewhere. 23 These differences were significant for all vascular procedures analyzed, with the exception of CEA and EVAR. To date, vascular surgery patients have not been considered at high-risk for pulmonary embolism/deep vein thrombosis. 24 However, our data suggest that the common view of low deep vein thrombosis risk in vascular patients should be challenged with more focused research and that more aggressive deep vein thrombosis prophylaxis treatment is warranted in patients undergoing vascular procedures, in particular, patients having AKAs.
Data in our study show that the majority of patients undergoing vascular procedures have several listed comorbidities, with Ͻ10% of all patients with no coded secondary diagnosis. Current risk adjustments try to capture the case mix, and we also refine vascular risk adjustment with the addition procedure indication. Applicable to many surgical fields, this concept is especially important in vascular surgery, in which a given procedure can be performed for a variety of reasons, or indications. Three of our index procedures fall into this category. All (ie, AFB, LEE, and LEB) are performed to correct impairments in blood flow in the lower extremity, and all can be offered (at one extreme) to patients inconvenienced by calf cramping after a block of walking (claudication) or, at the other extreme, to a bedridden patient with gangrene of the foot. We have shown, not surprisingly, that the more dire indications strongly predict adverse events, with a considerable linear increase in risk-adjusted PSI rates with disease severity. These differences in risk-adjusted rates might likely be an effect of disease severity that is not captured in the current risk adjustments, so indication for surgery is a critical component of case mix, and must be accounted for in benchmarks or prediction models for vascular surgery.
There have been mixed reports about the relationship between volume, teaching status, and urban hospitals and rates of PSIs. 5, 16, 25 Our data support the volume-outcomes relationship and provide additional evidence that highvolume hospitals have superior outcomes through the measurement of inpatient adverse event risk-adjusted rates. In vascular patients, we show that lower hospital volume is associated with higher PSI risk-adjusted rates. The reasons for this volume-event relationship are unclear. Highervolume hospitals might have more resources designed to promote patient safety. Alternatively, their practitioners might be more alert to potential complications because of greater previous experience with them. These findings merit additional analysis and have broad implications for public policy, such as vascular surgery resource allocation.
It is important to have a holistic view of patient safety within a surgical specialty, such as vascular surgery. Evidence-based quality indicators, such as AHRQ's PSIs, are becoming a standardized way to measure potential lapses of quality in health care systems and are a widely used surgical quality-benchmarking tool. Data presented in this report highlight important differences in risk-adjusted rates of adverse events in different procedures and subpopulations of patients receiving vascular surgery. These data can be used to benchmark the expected occurrence rates of different adverse events at a national level in vascular surgery and for individual vascular procedures.
Limitations
This study has important limitations. First, we identified adverse events and procedure indication using administrative data, which results in miscoded events and incomplete risk adjustment due to ICD-9 coding limitations and completeness for secondary diagnoses. 11, 26 Although principal diagnosis is accurately coded in administrative data, secondary or comorbid diagnoses are often under-reported. However, this is indirectly controlled for in the software using the Elixhauser method of comorbidity adjustment. Our study did not compare hospital performance, a situation that requires more attention to the limitations of risk adjustment. Another concern is the low positive predictive value of preventable adverse events due to the possibility of including present on admission conditions. 6, 27 Certain PSIs are greatly influenced by the inclusion of present on admission information and the validity of these rates is questionable in the absence of present on admission codes. [28] [29] [30] PSI software now imputes present on admission data at the hospital level in an attempt to address this concern, although patient-level data are not available in the NIS. Despite these limitations, PSIs are used for safety monitoring across the nation, and are often considered an important first step in identifying clinical targets for more detailed clinical data exploration.
CONCLUSIONS
Using AHRQ's PSIs on administrative data to monitor potential adverse events in major vascular procedures can identify several important areas of focus for qualityimprovement efforts. During the 5-year study period, we identified 1.4 million peripheral vascular operations and 73,135 potentially preventable adverse events. Data from this report reveal that the majority of patient safety events in vascular surgery occurred at significantly higher rates compared with all other surgical inpatients. We noted substantial disparities in PSI rates among vascular patients, with an event developing in higher percentages of blacks and Hispanics and those patients with a public payer, both Medicaid and Medicare. Procedure indication was highly associated with risk of a patient safety event developing in bypass operations. Patient safety events were also negatively associated with hospital volume. As in-hospital adverse events considerably increase a patient's length of stay, associated hospital charges, and inpatient mortality, it is important to note the overall higher rates of adverse events occurring in vascular patients and appropriately adjust set benchmarks for this surgical specialty, with the inclusion of procedure indication in the risk adjustments. It is apparent that better patient safety and higher surgical quality can be achieved by prioritizing quality improvement in procedures with the highest level of adverse events. The degree and type of adverse event in vascular surgery might be under-recognized, particularly for amputation patients with gangrene and overall vascular surgery deep vein thrombosis rates.
